why not? - she has a poor track record when it comes to following through on breakouts, just look at the chart - still you never know, it might this time.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025